PROPENSITY SCORE-MATCHED ANALYSIS OF NEOADJUVANT VS. ADJUVANT THERAPY IN RENAL CELL CARCINOMA

被引：0
|
作者：
Cesare, Saitta [1 ]
Mimi, V. Nguyen [1 ]
Giacomo, Musso [1 ]
Kevin, Hakimi [1 ]
Dattatraya, Patil [1 ]
Hajime, Tanaka [1 ]
Luke, Wang [1 ]
Margaret, F. Meagher [1 ]
Dhruv, Puri [1 ]
Kit, Yuen [1 ]
Masaki, Kobayashi [1 ]
Shohei, Fukuda [1 ]
Giuseppe, Garofano [1 ]
Giovanni, Lughezzani [1 ]
Nicolo, Buffi [1 ]
Viraj, Master [1 ]
Ithaar, H. Derweesh [1 ]
机构：
[1] UC San Diego Hlth Syst, Dept Urol, San Diego, CA USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2025年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.urolonc.2024.12.051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
    Yadav, S.
    Xie, H.
    Riaz, I. B.
    Sharma, P.
    Mahipal, A.
    McWilliams, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
    Yadav, Siddhartha
    Xie, Hao
    Bin-Riaz, Irbaz
    Sharma, Prabin
    Durani, Urshila
    Goyal, Gaurav
    Borah, Bijan
    Borad, Mitesh J.
    Smoot, Rory L.
    Roberts, Lewis R.
    Go, Ronald S.
    McWilliams, Robert R.
    Mahipal, Amit
    EJSO, 2019, 45 (08): : 1432 - 1438
  • [3] A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN
    Saitta, Cesare
    Nguyen, Mimi V.
    Hakimi, Kevin
    Patil, Dattatraya
    Tanaka, Hajime
    Afari, Jonathan A.
    Cortes, Julian
    Roberts, Jacob
    Meagher, Margaret F.
    Liu, Franklin
    Mahmood, Mirha
    Matian, Joshua
    Mansour, Mariam
    Puri, Dhruv
    Cerrato, Clara
    Yuen, Kit L.
    Kobayashi, Masaki
    Fukuda, Shohei
    Chen, Wei
    Nicaise, Edouard
    Imtiaz, Nahar
    Greenwald, Rachel
    Master, Viraj
    Fujii, Yasuhisa
    McKay, Rana
    Derweesh, Ithaar H.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E142 - E143
  • [4] Comparative analysis of outcomes of neoadjuvant and adjuvant systemic therapy in non-metastatic renal cell carcinoma: A propensity score-matched analysis from the INMARC registry.
    Saitta, Cesare
    Nguyen, Mimi
    Hakimi, Kevin
    Afari, Jonathan
    Patil, Dattatraya H.
    Tanaka, Hajime
    Wang, Luke
    Meagher, Margaret F.
    Liu, Franklin
    Puri, Dhruv
    Cerrato, Clara
    Yuen, Kit
    Kobayashi, Masaki
    Fukuda, Shohei
    Master, Viraj A.
    Fujii, Yasuhisa
    Lane, Brian R.
    Derweesh, Ithaar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [5] Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data
    Watanuki, Rurina
    Hayashida, Tetsu
    Yokoe, Takamichi
    Kawai, Yuko
    Kikuchi, Masayuki
    Nakashoji, Ayako
    Nagayama, Aiko
    Seki, Tomoko
    Takahashi, Maiko
    Kitagawa, Yuko
    BREAST JOURNAL, 2020, 26 (09): : 1765 - 1770
  • [6] Neoadjuvant therapy versus surgery first for ampullary carcinoma: A propensity score-matched analysis of the NCDB
    Guo, Marissa
    Beal, Eliza W.
    Miller, Eric D.
    Williams, Terence M.
    Tsung, Allan
    Dillhoff, Mary
    Ejaz, Aslam
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (07) : 1558 - 1567
  • [7] Neoadjuvant Versus Adjuvant Chemoradiotherapy for Stage II-III Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
    Li, T.
    Lv, J.
    Wang, Q.
    Han, Y.
    Song, Y.
    Liang, L.
    Chen, M. H.
    Fan, Y.
    Wu, L.
    Peng, L.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E190 - E190
  • [8] The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
    Deng, Xuyang
    He, Wenwu
    Jiang, Yingchun
    Deng, Sijie
    Mao, Tianqin
    Leng, Xuefeng
    Luo, Qiyu
    Zheng, Kai
    Han, Yongtao
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [9] Neoadjuvant versus adjuvant chemoradiotherapy for stage II-III esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Han, Yongtao
    Song, Yuzhe
    Liang, Long
    Chen, Meihua
    Fan, Yu
    Wu, Lei
    Peng, Lin
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma:A retrospective,propensity score-matched study
    Yang Li
    Fu-Hai Ma
    Li-Yan Xue
    Yan-Tao Tian
    World Journal of Gastroenterology, 2020, (08) : 818 - 827
12345